Results 251 to 260 of about 4,732,777 (361)

Treatment and Outcomes for Patients With Inadequate Lymphadenectomy After Resection of Stage II Small Bowel Adenocarcinoma

Journal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objectives Adjuvant chemotherapy (AC) is considered for patients with stage II small bowel adenocarcinoma (SBA) with an inadequate lymphadenectomy; however, the prognostic role of additional high‐risk features (T4 primary, positive resection margin, poorly differentiated tumor, or lymphovascular invasion) is unknown.
Jackson A. Baril, Karl Y. Bilimoria, Eugene P. Ceppa, Michael G. House, Thomas K. Maatman, Alexandra M. Roch, Anthony D. Yang, C. Max Schmidt, Ryan J. Ellis   +8 more
wiley   +1 more source

Evolving concepts in adjuvant/neoadjuvant therapy for resectable pancreas cancer. [PDF]

J Clin Invest
Bryant JM, Ruffolo L, Soares K, Hoffe S, Lowy AM.   +4 more
europepmc   +1 more source

Changing Practices in Axillary Surgery After Neoadjuvant Breast Cancer Therapy: Insights From the EUSOMA European Database

Journal of Surgical Oncology, EarlyView.
ABSTRACT Introduction Sentinel lymph node biopsy (SLNB) after neoadjuvant treatment (NAT) is an increasing option for axillary surgery in patients responding to treatment, whether diagnosed as clinically node‐negative (cN0) or node‐positive (cN + ). This study evaluates SLNB trends in patients with NAT in a large European population.
Antonio J. Esgueva, Mariano Tomatis, Antonio Ponti, Lorenza Marotti, Maria Joao Cardoso, Kwok Leung Cheung, Jakob De Vries, Peter van Dam, Isabel T. Rubio, The Eusoma Working group, Chiara Annunziata Pasqualina Anghelone, Antonella Baldissera, Elisabetta Benozzi, Martine Berlière, Marina Bortul, Barbara Bussels, Francesco Caruso, Carla Cedolini, Fabio Corsi, Evelyn Despierre, Boudewijn Dullens, Gianluca Fogazzi, Lucio Fortunato, José Luis Fougo, Gianluca Frisoni, Daniele Generali, Alessandra Gennari, Matteo Ghilli, Marco Golinelli, Pedro Gouveia, Simona Grossi, Ruth Helfgott, Alessandra Huscher, Karolina F. Larsson, Sophie Marquette, Carmela Mocerino, Ida Negreiros, Francesca Pellini, Federico Piacentini, Romano Polato, Annemie Prové, Karol Rogowski, Giovanna Romanucci, Lorenzo Rossi, Claudia Francesca Rossi, Margherita Serra, Gracienne Staelens, Maud Vassilieff, Paolo Veronesi, Daniele Zanoni   +49 more
wiley   +1 more source

Predicting esophageal cancer response to neoadjuvant therapy with magnetic resonance imaging radiomics. [PDF]

World J Gastrointest Oncol
Yang RH, Fan WX, Zhong Y, Lin ZP, Chen JP, Jiang GH, Dai HY.   +6 more
europepmc   +1 more source

Neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer: reconstructed patient-level meta-analysis of randomized clinical trials

Daniel Aliseda, Pablo Martí‐Cruchaga, Gabriel Zozaya, Nuria Blanco, Mariano Ponz‐Sarvisé, Á. Chopitea, Javier Rodríguez, Eduardo Castañón, Fernando Pardo, Fernando Rotellar   +9 more
openalex   +1 more source

Impact of Combined Additional Resections on the Surgical Outcomes of Robot‐Assisted Resection of Thymic Epithelial Tumors

Journal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objectives Robot‐assisted thoracoscopy (RATS) is rapidly emerging as the preferred approach for the resection of thymic epithelial tumors (TET). Current challenges include the role of RATS in locally advanced disease and combined additional resections.
Benedikt Niedermaier, Nabil Khan, Florian Eichhorn, Maria Zehentmeier, Heidrun Grosch, Raffaella Griffo, Alessio Campisi, Antonia Margineanu, Michael Allgäuer, Petros Christopoulos, Michael Thomas, Hauke Winter, Martin E. Eichhorn   +12 more
wiley   +1 more source

Rethinking Neoadjuvant Therapy: A Critical Evaluation of Exclusion Criteria in Gastric Cancer Surgery Studies. [PDF]

J Gastric Cancer
Ilhan Y, Guzel HG, Balcik OY.
europepmc   +1 more source

A Systematic Mapping Review of Core Outcome Reporting in Surgical Research for Oesophageal Cancer

Journal of Surgical Oncology, EarlyView.
ABSTRACT Oesophageal carcinoma is a rising global health burden, with surgical resection and perioperative chemotherapy forming the cornerstone of curative treatment. However, uncertainty persists regarding the optimal surgical approach, partly due to heterogeneity in outcome reporting, which hinders data synthesis and evidence‐based decision‐making ...
Nadia Matias, Anie Naqvi, Jack Thomson, Roukia Techache, Kerry Avery, Natalie Blencowe, Rhiannon Macefield, Bilal Alkhaffaf   +7 more
wiley   +1 more source

Expression of carcinoma ecotypes in the tumor microenvironment predicts response to neoadjuvant therapy in early-stage breast cancer. [PDF]

Sci Rep
Asleh K, Bethune G, Marcato P.
europepmc   +1 more source

Prescription of Physical Activity for Patients with Rectal Cancer during Neoadjuvant Therapy

, 2010
Abraham Martínez Ruiz, María del Carmen Fiuza Luces, Itziar Págola Aldazabal, Ana Soria, B. Ludeña, Daniel Huerga   +5 more
openalex   +1 more source